Index Performance
-7.25%
Synbio Average
-6.46%
IBB
Overview
Description
Synthetic biology companies identified by AI with human in the loop. Minimum $1b market cap.
- Inception Date01/08/2024
- WeightingCustom
- # of holdings25
What's inside?
Holdings
All holdings as of April 26, 2024
CSV download
| Neurocrine Biosciences, Inc. (NBIX) | 6.58% | $13.53B | 26.76% | 96.95% | 6.75 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 6.57% | $102.67B | 12.47% | 87.17% | 9.71 |
| Johnson & Johnson (JNJ) | 6.22% | $352.17B | -13.55% | 74.59% | N/A |
| Pfizer Inc. (PFE) | 6.12% | $143.43B | -41.70% | 50.06% | 3.88 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 5.77% | $14.48B | 6.26% | 48.26% | 1.85 |
| Bristol Myers Squibb Co. (BMY) | 5.77% | $90.92B | 4.66% | 55.54% | 3.46 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | 5.63% | $7.71B | N/A | N/A | N/A |
| Catalent, Inc. (CTLT) | 5.58% | $10.12B | -10.88% | 16.70% | 3.15 |
| BridgeBio Pharma, Inc. (BBIO) | 5.07% | $4.66B | -88.02% | 29.70% | 846.17 |
| Charles River Laboratories International, Inc. (CRL) | 4.96% | $11.76B | 3.86% | 33.70% | 3.65 |
| Insmed, Inc. (INSM) | 4.33% | $3.68B | 24.39% | 76.86% | 16.17 |
| Certara, Inc. (CERT) | 4.03% | $2.65B | 5.57% | 47.35% | 8.07 |
| Amicus Therapeutics, Inc. (FOLD) | 4.02% | $3.04B | 21.30% | 88.68% | 10.89 |
| Denali Therapeutics, Inc. (DNLI) | 3.44% | $2.20B | 204.74% | 94.94% | 5.95 |
| CRISPR Therapeutics AG (CRSP) | 3.32% | $4.58B | 30,885.48% | 59.57% | 9.44 |
| Schrödinger, Inc. (SDGR) | 3.10% | $1.52B | 19.73% | 64.66% | 10.82 |
| Prothena Corp. Plc (PRTA) | 2.70% | $1.12B | 69.50% | 90.79% | 14.51 |
| Intellia Therapeutics, Inc. (NTLA) | 2.47% | $2.00B | -30.40% | 75.26% | 52.65 |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2.44% | $1.87B | 11.88% | -14.61% | 38.26 |
| Inhibrx, Inc. (INBX) | 2.18% | $1.61B | -17.36% | 33.83% | 957.31 |
| Twist Bioscience Corp. (TWST) | 2.10% | $1.82B | 31.81% | 40.51% | 7.24 |
| Beam Therapeutics, Inc. (BEAM) | 2.03% | $1.75B | 520.01% | 94.70% | 2.87 |
| Protagonist Therapeutics, Inc. (PTGX) | 1.95% | $1.47B | 125.73% | 94.48% | 16.02 |
| Morphic Holding, Inc. (MORF) | 1.82% | $1.41B | -100.00% | N/A | N/A |
| AbCellera Biologics, Inc. (ABCL) | 1.79% | $1.10B | -92.17% | 18.75% | 24.76 |
Market data by FactSet
